Position in BMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$13,638,942
-$1,074,262 QoQ
Shares Held
236,705
-2.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#340
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cannell & Spears LLC holds $208,924,357 across 12 Drug Manufacturers - General names. BMY ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
557,332 | $71,617,162 | |
| 2 | ABBV |
AbbVie Inc.
|
255,977 | $64,414,052 | |
| 3 | JNJ |
Johnson & Johnson
|
169,381 | $43,017,692 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
236,705 | $13,638,942 | |
| 5 | PFE |
Pfizer Inc
|
236,223 | $5,688,249 | |
| 6 | LLY |
ELI LILLY & Co
|
3,814 | $4,574,626 | |
| 7 | AMGN |
Amgen Inc
|
8,507 | $3,080,554 | |
| 8 | BIIB |
Biogen Inc.
|
5,083 | $1,098,232 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,638,942 | 236,705 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $14,713,204 | 242,592 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,567,528 | 251,530 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,406,421 | 252,914 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,548,802 | 271,091 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,581,290 | 271,869 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,357,567 | 271,527 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $14,144,784 | 273,382 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,241,506 | 270,684 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $15,735,919 | 290,170 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $658,307 | 12,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $764,618 | 13,174 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $842,477 | 13,174 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $913,089 | 13,174 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $923,118 | 12,830 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $894,312 | 12,580 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $973,896 | 12,648 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $944,496 | 12,933 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $818,842 | 13,133 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $760,216 | 12,848 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $858,503 | 12,848 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $621,704 | 9,848 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $620,486 | 10,003 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $603,080 | 10,003 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $588,176 | 10,003 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $571,725 | 10,257 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||